key: cord-0823682-17dw6yq2
authors: Suzuki, Tetsuya; Hayakawa, Kayoko; Ainai, Akira; Iwata-Yoshikawa, Naoko; Sano, Kaori; Nagata, Noriyo; Suzuki, Tadaki; Wakimoto, Yuji; Akiyama, Yutaro; Miyazato, Yusuke; Nakamura, Keiji; Ide, Satoshi; Nomoto, Hidetoshi; Nakamoto, Takato; Ota, Masayuki; Moriyama, Yuki; Sugiki, Yuko; Saito, Sho; Morioka, Shinichiro; Ishikane, Masahiro; Kinoshita, Noriko; Kutsuna, Satoshi; Ohmagari, Norio
title: Effectiveness of Personal Protective Equipment in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Healthcare Workers
date: 2020-09-09
journal: J Infect Chemother
DOI: 10.1016/j.jiac.2020.09.006
sha: fc85f44a7c9e27572b20b53a879a0afee2df2f21
doc_id: 823682
cord_uid: 17dw6yq2

Introduction Information on the effectiveness of personal protective equipment (PPE) for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among healthcare workers (HCWs), especially among HCWs with frequent contact with patients with SARS-CoV-2, is limited. Methods We conducted a prospective cohort study on 49 HCWs who worked in close contact with patients with SARS-CoV-2 infection. HCWs had blood samples taken every 2 weeks to test for SARS-CoV-2 antibodies using two different types of assay. Results Forty-nine participants (31 nurses, 15 doctors, 3 other workers) were enrolled. In total, 112 blood samples are obtained from participants. The median work days in 2 weeks was 9 (interquartile range (IQR): 5-10) days. In a single work day, 30 of the 49 participants (61.5%) had contact with patients with suspected or conformed SARS-CoV-2 at least 8 times, and approximately 60% of participants had more than 10 minutes of contact with a single patient. The median self-reported compliance to PPE was 90% (IQR: 80-100%). Seven participants tested positive for SARS-CoV-2 antibody using enzyme-linked immunosorbent assay (ELISA); however, none were seropositive for SARS-CoV-2 neutralizing antibody, so the positive ELISA results were assumed to be false-positive. Conclusions The study provides evidence that appropriate PPE is sufficient to prevent infection amongHCWs. It is necessary to establish a system that provides a stable supply of PPE for HCWs to perform their duties.

Since the first cases were reported in December 2019, coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic [1] . In Japan, the first case was reported in mid-January 2020, and more than 16,000 cases had been reported as of May 31, 2020 [2] . The World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) guidelines on prevention of SARS-CoV-2 infection in healthcare settings [3, 4] recommend wearing personal protective equipment (PPE) including masks, gowns, gloves, and eye protection, when providing direct care to COVID-19 patients. Many healthcare workers (HCWs) have been infected with SARS-CoV-2 [5] , including almost 10,000 HCWs in the US [6] . In HCWs with SARS-CoV-2 infection, it is difficult to determine HCWs whether they acquired the infection at work or in the community. Information on the effectiveness of PPE at preventing infection among HCWs is limited. In Japan, there were only 528 cases of COVID-19 reported in Tokyo by the end of March 2020, and the risk of community-acquired infection during this period was limited [7] . Our hospital is a designated infectious disease hospital and we have been promoting infection control since before COVID-19 endemic, so compliance with PPE use is likely to be high. For patient care, airborne precautions (N95 mask) and contact precautions (gloves, gown, cap) are used. Eye shields are also used according to WHO and CDC recommendations [2, 3] . Alcohol hand sanitizers are available for hand hygiene. During aerosol-producing procedures (e.g., intubation, extubation, and bronchoscopy), a powered air-purifying respirator and coverall are used.

Under these circumstances, it was possible to evaluate the effectiveness of PPE against acquiring SARS-CoV-2 infection at work. We conducted an observational study of HCWs to determine the effectiveness of PPE at preventing SARS-CoV-2 infection.

This single-center prospective cohort study was conducted in National Center for Global Health and Medicine. We recruited participants and collected blood samples between February 14 and April 3, 2020. This study was approved by the Ethics Committee of the Center Hospital of the National Center for Global Health and Medicine. Written informed consent was obtained from all participants.

HCWs with close contact with COVID-19 patients were recruited for the study. Close contact was defined as either talking with patients at close range (within 1 m), touching patients for examination and/or care, or taking samples such as nasopharyngeal swabs or blood. Blood samples of HCWs were obtained at enrolment and every 2 weeks after enrolment until April 3,

At enrolment, participants answered a web-based self-reported questionnaire about their compliance with PPE use. The questionnaire included questions about participants' PPE use during the previous 2 weeks, their compliance, and details of their exposures at enrolment and at every blood sampling.

In order to minimize the possibility of false-negative results, serum SARS-CoV-2 antibody titres were measured using an enzyme-linked immunosorbent assay (ELISA) and a neutralization assay. There is limited evidence of the effectiveness of the PPE against SARS-CoV-2. Wang et al. [9] recently reported the potential role of PPE use in the protection against COVID-19 using the cohort of HCWs who were dispatched to work in Wuhan. They found that none of the HCWs were infected with COVID-19 using throat swab samples for SARS-CoV-2 real-time reverse transcription polymerase chain reaction as well as specific antibody levels measured with immunoglobulin M, immunoglobulin G, and immunoglobulin A by chemiluminescent kits. We used more sensitive laboratory tests and included HCWs with greater exposure to SARS-CoV-2.

The accuracy of screening of the serostatus of a population with low infection prevalence is uncertain. To minimize the false-negative and false-positive results, we used two different antibody tests: ELISA using SARS-CoV-2 antigen to enhance sensitivity and neutralizing J o u r n a l P r e -p r o o f 8 antibody to enhance specificity. The 7 samples that were seropositive on ELISA tested negative with the neutralization assay, and hence, were considered to be false positives.

A previous study revealed that the sensitivity of antibody tests in COVID-19 patients in 15-39 days after onset is 100% [10] . Our hospital started admitting COVID-19 patients in January 26, 2020, and so participants had sufficient time to develop antibodies if they had been infected. Most patients were admitted to our hospital as soon as they were diagnosed with COVID-19 and are likely to have been infectious during their hospitalization [11] .

SARS-CoV-2 infections among HCWs can occur due to lack of PPE, improper use of PPE, or infection in the community [5] . Our findings suggest that the proper use of airborne and contact precautions can prevent SARS-CoV-2 infection among exposed HCWs. Nevertheless, it is important to avoid unnecessary contact with COVID-19 patients. In conclusion, the study provides evidence that appropriate PPE is sufficient to prevent infection among health care workers. It is necessary to establish a system that provides a stable supply of PPE for HCWs to perform their duties. To improve compliance to PPE, it is important to promote further research on PPE innovation. 

Coronavirus disease 2019 (COVID-19): research progress and clinical practice

World Health Organization. Coronavirus disease (COVID-2019) situation reports

World Health Organization. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance

Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Characteristics of health care personnel with COVID-19 -United States

Featured Website: novel coronavirus disease

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Association of personal protective equipment use with successful protection against COVID-19 infection among health care workers

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

Virological assessment of hospitalized patients with COVID-2019